FAVA, PAOLO
FAVA, PAOLO
SCIENZE MEDICHE
A traveller's wart: tungiasis
2018-01-01 Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro
Activity Of Imatinib Mesilate In Metastatic Melanoma
2014-01-01 Savoia Paola; Fava Paolo
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era
2021-01-01 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
After Surgery: Follow-Up Guidelines of Melanoma Patients
2013-01-01 Paolo Fava; Pietro Quaglino; Maria Grazia Bernengo; Paola Savoia
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit
2021-01-01 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T.
Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant.
2017-01-01 Licciardello M, Giura M.T., Rozzo G., Marra E, Fava P., Astrua C., Contu V., Lista P., Fierro M.T., Quaglino P., Ribero, S.
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study
2017-01-01 Queirolo, Paola; Dozin, Beatrice; Morabito, Anna; Banelli, Barbara; Piccioli, Patrizia; Fava, Cristiana; Leo, Claudio; Carosio, Roberta; Laurent, Stefania; Fontana, Vincenzo; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Battaglia, Angelo; Ascierto, Paolo A.; Capone, Mariaelena; Simeone, Ester; De Galitiis, Federica; Pagani, Elena; Cappellini, Gian Carlo Antonini; Marchetti, Paolo; Guida, Michele; Tommasi, Stefania; Mandalà, Mario; Merelli, Barbara; Quaglino, Pietro; Fava, Paolo; Guidoboni, Massimo; Romani, Massimo; Spagnolo, Francesco; Pistillo, Maria Pia*
Atopic dermatitis in a phenylketonuric untreated patient
2015-01-01 Fava p; Fierro MT; Brizio M; Marra E; Spada M; Bernengo MG
Attività clinica e modulazione immunologica di bexarotene a basse dosi: presentazione di un caso
2008-01-01 Quaglino Pietro; Marenco Federica; Fava Paolo; Bernengo Maria Grazia
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study
2019-01-01 Pileri A.; Fava P.; Fuligni F.; Gunnella S.; Guglielmo A.; Astrua C.; Grandi V.; Simontacchi G.; Patrizi A.; Quaglino P.; Pimpinelli N.
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up.
2015-01-01 Novelli M; Fava P; Sarda C; Ponti R; Osella-Abate S; Savoia P; Bergallo M; Lisa F; Fierro MT; Quaglino P.
BRAFi/MEKi in patients with metastatic melanoma: Predictive factors of complete response
2019-01-01 Ribero, Simone*; Malavenda, Ottavia; Fava, Paolo; Astrua, Chiara; Marra, Elena; Osella-Abate, Simona; Sanlorenzo, Martina; Caliendo, Virginia; Fierro, Maria Teresa; Quaglino, Pietro
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway
2012-01-01 Quaglino P; Antiga E; Novelli M; Nardò T; Fava P; Ponti R; Osella-Abate S; Caproni M; Fabbri P; Bernengo MG
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study
2022-01-01 Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A.
Characterization and management of cutaneous side effects related to the immunosuppressive treatment in solid organ recipients
2016-01-01 Savoia, Paola; Ranghino, Andrea; Fava, Paolo
Clinical and pathological relevance of drug-induced vitiligo in patients treated for metastatic melanoma with anti-PD1 or BRAF/MEK inhibitors
2020-01-01 Ramondetta A.; Ribero S.; Conti L.; Fava P.; Marra E.; Broganelli P.; Caliendo V.; Picciotto F.; Guida M.; Ierro M.T.; Quaglino P.
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness
2023-01-01 Mannino, Maria; Piccerillo, Alfredo; Fabbrocini, Gabriella; Quaglino, Pietro; Argenziano, Giuseppe; Dika, Emi; Ascierto, Paolo Antonio; Pellacani, Giovanni; Longo, Caterina; Fargnoli, Maria Concetta; Bianchi, Luca; Calzavara-Pinton, Piergiacomo; Zalaudek, Iris; Fava, Paolo; Scalvenzi, Massimiliano; Bocchino, Enrico; Di Stefani, Alessandro; Peris, Ketty
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials
2021-01-01 Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P.
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients.
2013-01-01 Quaglino P; Nardò T; Fierro MT; Massaia M; Orsucci L; Fava P; Marenco F; Marra E; Savoia P; Vitolo U; Boccadoro M; Bernengo M.
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance
2010-01-01 Fierro MT; Ponti R; Titli S; Fava P; Novelli M; Quaglino P; Bernengo MG
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A traveller's wart: tungiasis | 2018 | Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro | |
| Activity Of Imatinib Mesilate In Metastatic Melanoma | 2014 | Savoia Paola; Fava Paolo | |
| Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era | 2021 | Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone | |
| After Surgery: Follow-Up Guidelines of Melanoma Patients | 2013 | Paolo Fava; Pietro Quaglino; Maria Grazia Bernengo; Paola Savoia | |
| Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit | 2021 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T. | |
| Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant. | 2017 | Licciardello M, Giura M.T., Rozzo G., Marra E, Fava P., Astrua C., Contu V., Lista P., Fierro M.T., Quaglino P., Ribero, S. | |
| Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study | 2017 | Queirolo, Paola; Dozin, Beatrice; Morabito, Anna; Banelli, Barbara; Piccioli, Patrizia; Fava, Cristiana; Leo, Claudio; Carosio, Roberta; Laurent, Stefania; Fontana, Vincenzo; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Battaglia, Angelo; Ascierto, Paolo A.; Capone, Mariaelena; Simeone, Ester; De Galitiis, Federica; Pagani, Elena; Cappellini, Gian Carlo Antonini; Marchetti, Paolo; Guida, Michele; Tommasi, Stefania; Mandalà, Mario; Merelli, Barbara; Quaglino, Pietro; Fava, Paolo; Guidoboni, Massimo; Romani, Massimo; Spagnolo, Francesco; Pistillo, Maria Pia* | |
| Atopic dermatitis in a phenylketonuric untreated patient | 2015 | Fava p; Fierro MT; Brizio M; Marra E; Spada M; Bernengo MG | |
| Attività clinica e modulazione immunologica di bexarotene a basse dosi: presentazione di un caso | 2008 | Quaglino Pietro; Marenco Federica; Fava Paolo; Bernengo Maria Grazia | |
| Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study | 2019 | Pileri A.; Fava P.; Fuligni F.; Gunnella S.; Guglielmo A.; Astrua C.; Grandi V.; Simontacchi G.; Patrizi A.; Quaglino P.; Pimpinelli N. | |
| Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. | 2015 | Novelli M; Fava P; Sarda C; Ponti R; Osella-Abate S; Savoia P; Bergallo M; Lisa F; Fierro MT; Quaglino P. | |
| BRAFi/MEKi in patients with metastatic melanoma: Predictive factors of complete response | 2019 | Ribero, Simone*; Malavenda, Ottavia; Fava, Paolo; Astrua, Chiara; Marra, Elena; Osella-Abate, Simona; Sanlorenzo, Martina; Caliendo, Virginia; Fierro, Maria Teresa; Quaglino, Pietro | |
| Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway | 2012 | Quaglino P; Antiga E; Novelli M; Nardò T; Fava P; Ponti R; Osella-Abate S; Caproni M; Fabbri P; Bernengo MG | |
| CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study | 2022 | Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A. | |
| Characterization and management of cutaneous side effects related to the immunosuppressive treatment in solid organ recipients | 2016 | Savoia, Paola; Ranghino, Andrea; Fava, Paolo | |
| Clinical and pathological relevance of drug-induced vitiligo in patients treated for metastatic melanoma with anti-PD1 or BRAF/MEK inhibitors | 2020 | Ramondetta A.; Ribero S.; Conti L.; Fava P.; Marra E.; Broganelli P.; Caliendo V.; Picciotto F.; Guida M.; Ierro M.T.; Quaglino P. | |
| Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness | 2023 | Mannino, Maria; Piccerillo, Alfredo; Fabbrocini, Gabriella; Quaglino, Pietro; Argenziano, Giuseppe; Dika, Emi; Ascierto, Paolo Antonio; Pellacani, Giovanni; Longo, Caterina; Fargnoli, Maria Concetta; Bianchi, Luca; Calzavara-Pinton, Piergiacomo; Zalaudek, Iris; Fava, Paolo; Scalvenzi, Massimiliano; Bocchino, Enrico; Di Stefani, Alessandro; Peris, Ketty | |
| Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials | 2021 | Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P. | |
| Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. | 2013 | Quaglino P; Nardò T; Fierro MT; Massaia M; Orsucci L; Fava P; Marenco F; Marra E; Savoia P; Vitolo U; Boccadoro M; Bernengo M. | |
| Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance | 2010 | Fierro MT; Ponti R; Titli S; Fava P; Novelli M; Quaglino P; Bernengo MG |